BioEdge 213 -- Tuesday, 8 August 2006

Home   |    Archives   |    Links   |    In the media
subscribe   |    subscribe my friend   |    to the editor   |    unsubscribe
BioEdge 213: Mail order embryos

THIS WEEK


bullet 
Mail order embryos
      Quality merchandise guaranteed
bullet 
Pressure maintained for Australian therapeutic cloning
      PM defers final decision
bullet 
Conscientious objection grows in the US
      Techology and ethics collide
bullet 
Nip and tuck in Brazil
      Cosmetic surgery thrives in the tropics
bullet 
Is there a constitutional right to experimental drugs?
      Drug companies aghast
bullet 
Exploitation in Pakistan
      Children making surgical tools
bullet 
IN BRIEF: Thailand; drug trial

MAIL ORDER EMBRYOS

Jennalee Ryan From Texas, the state where Michael Dell pioneered custom-built computers, come custom-built embryos. Commercialisation of the IVF process has achieved a new milestone with the world's first embryo bank at an innovative adoption agency in San Antonio. The Abraham Center of Life allows people to order custom-made embryos and have them shipped to an IVF clinic for implantation.

The embryos are created with the eggs and sperm of rigorously screened, "qualified" donors who have never met each other. Conception occurs as the embryo bank fills its orders. Customers can even specify the eye and hair colour that they would like their baby to have.

Jennalee Ryan, the director, says that her program is superior to both normal adoption and "adopting" surplus embryos in IVF clinics. Babies offered for adoption tend to come from lower class women, she says, who often have a history of drug or alcohol abuse. IVF embryos come from couples with fertility problems and the pregnancy rate is, at best, about 30%. Furthermore, adopting couples may have to deal with vexatious genetic parents. Often an adopting couple has to jump through hoops to prove that they will be good parents.

This new system skirts all these problems, offering a high probability of intelligent, healthy babies, without any interference from the biological parents. Most of her sperm donors have PhDs and most egg donors have had some tertiary education. All donors are medically screened and the medical quality of embryos is graded. With "proven" donors, the success rate for a pregnancy is around 70%, compared to IVF rates of about 30%. The centre can arrange for qualified surrogate mothers, if necessary. However, Ms Ryan told the London Daily Mail that most clients on her waiting list were not fussy about the characteristics of their embryos. They were happy just to get a child.

Like Dell's computers, the other advantage of buying embryos through the Abraham Center of Life is price. At about half the cost of adoption, it is "a cost-effective, highly successful option to infertility", says Ms Ryan. For US$10,000, customers will get two embryos.

Critics react. Ms Ryan acknowledged that there was some opposition to custom-built embryos, especially from religious groups. "But what I say to them is Jesus was not conceived in the normal way either. I don't lose any sleep over what we are doing. I feel what we are doing is positive. We are helping couples and putting good genes back into the universe."

The US media, for some reason, has largely ignored this novel business, despite a Ms Ryan's press release. However, Josephine Quintavalle of the British lobby group Comment on Reproductive Ethics, told the Daily Mail that it represented the "absolute commercialisation of human life... It is heartbreaking to see children reduced in this way to the equivalent of a special offer supermarket commodity: cut price, tailor-made human embryos, complete with door-to-door delivery."

Even utilitarian bioethicist Arthur Caplan, of the University of Pennslyvania, was revolted by Ms Ryan's entrepreneurial plans. "How do we get to the point where you go to jail if you go up to someone on the street and say, 'Do you want to buy my child for $10,000?' You'd think they were barbaric, immoral heinous people. But if they come down the street and say, 'Hey, there's an Internet site. Do you want to buy an egg, sperm and surrogate mother?' We think they're just entrepreneurs. What's going on here?" ~ Daily Mail, Aug 4   

PRESSURE MAINTAINED FOR AUSTRALIAN THERAPEUTIC CLONING

Australian Prime Minister John Howard Australian supporters of therapeutic cloning are pressing for a conscience vote in Federal Parliament despite opposition from Prime Minister John Howard and some prominent colleagues. Opponents had hoped that Howard would stop the push at a meeting of MPs from the governing coalition at the beginning of the new session. However, he left the matter unresolved and told MPs that he would hold a meeting to discuss the issue in a couple of weeks.

The influential health minister, Tony Abbott, says there must be limits on what scientists are allowed to do. "In my view, therapeutic cloning, so called, is a bridge too far," he said recently. He predicted a slippery slope: that scientists would eventually call for an extension of time for growing embryos in the lab. "In a few years time, they would be saying, let's let it go for 30 days. And a few years beyond that, we would have scientists of high standing telling us that we ought to let it go for three months and so on. I just think that it will be better for all of us if we don't go down this path."

If the issue were decided by a conscience vote in Parliament, the odds are that it would pass, as most of the media coverage has been favourable, focusing more upon the possibility of cures, the sincerity of scientists and the fear of passing up early entry into a huge new industry. "Australia stands to go backwards, socially and economically, if we don't act," wrote the premiers of the states of Victoria and Queensland. The acting chair of the Lockhart Committee, which recommended that the government legalise therapeutic cloning, agrees. She feels that moral objections will evaporate as soon as cures are delivered.

Surprisingly, one of the scientists who cloned Dolly the sheep opposes liberalisation. Dr Alan Colman, who is now working in Singapore, said that procuring the eggs needed for therapeutic cloning posed ethical problems for him. "I'm not one to slow down research but you have to ask is it worth pursuing with current techniques or better to wait for other technologies," Dr Colman told the Australian. "(Stem cell cloning) is a technique that could be useful but I think it's a bit crude and inefficient at the moment. The balance of probability of the process working against the aspect of human donors giving eggs is just not good enough." ~ Australian, Aug 3; Age, Aug 7; news.com.au, Aug 2   

CONSCIENTIOUS OBJECTION GROWS IN THE US

Conscientious objection is becoming more and more prominent in bioethical discussion, according to an article in the Washington Post. Growing religious fervour and the introduction of controversial new medical technologies are beginning to collide. "This issue is the San Andreas Fault of our culture," said Gene Rudd of the Christian Medical & Dental Associations. "How we decide this is going to have a long-lasting impact on our society."

Most conflicts are handled discretely, but often an explosive confrontation is possible, either because health care workers feel that they are being forced to act against deeply-held values or because they chafe under restrictions in a morally conservative institution.

Supporters of conscientious objection compare their view to conscientious objections to the Vietnam War and the recent refusal of anaesthetists in California to participate in executions. "Why is it that some people would have no compunction in forcing a doctor to participate in an abortion, but if it's painful death by lethal injection, they suddenly find religion?" asked Lynn D. Wardle of Brigham Young University's J. Reuben Clark Law School.

Referring patients elsewhere is always a tricky issue. Should a doctor who opposes abortions be forced to tell patients where they can get one? "Think about slavery," said physician William Toffler of the Oregon Health and Science University in Portland. "I am a blacksmith and a slave owner asks me to repair the shackles of a slave. Should I have to say, 'I can't do it but there's a blacksmith down the road who will?' "

However, bioethicists of a utilitarian persuasion argue that a health care worker's first responsibility is do what they are asked. "As soon as you become a licensed professional, you take on certain obligations to act like a professional, which means your patients come first," said R. Alta Charo, a bioethicist and lawyer at the University of Wisconsin at Madison. "You are not supposed to use your professional status as a vehicle for cultural conquest." ~ Washington Post, July 16   

NIP AND TUCK IN BRAZIL

Brazilian cosmetic surgeons have become world leaders in reducing the size of bellies and buttocks, says a report in the UK Guardian about the biannual meeting of the International Society of Aesthetic Surgery. There are 4,000 cosmetic surgeons in Brazil working in this lucrative industry, not far behind the US, which has 5,000. Although no figures are available on the size of the market, it is probably not far behind the US$12.4 billion spent in the US. As in other countries, it is no longer a taboo subject -- celebrities talk openly about their operations and several glossy magazines are dedicated to the topic.

Surgeons explain that Brazilian society is particularly congenial to their trade. "Brazilians have a much greater ease in seeking out plastic surgery," says the outgoing president of ISAPS. "It is a tropical country, where people enjoy exposing their bodies. This helps stimulate people to have surgery." New, less invasive techniques offered by walk-in clinics are making it popular amongst lower-income groups, as well.

Brazilian expertise is being exported, not always with the happiest of outcomes. In Boston, a woman died and another was hospitalised after cosmetic surgery at the hands of Luiz Carlos Riberio, who claims to be a doctor. He and his wife could be charged with manslaughter or murder. Apparently the couple had been visiting Boston from Brazil for at least two years on short-term work visas. They had set up a clinic in the basement of a condominium where they performed liposuction, lip plumping and nose sculpting for low- income Brazilian migrants. ~ Guardian, Aug 7; Boston Globe, Aug 1   

IS THERE A CONSTITUTIONAL RIGHT TO EXPERIMENTAL DRUGS?

Doctors and drug companies in the US fear that the nation's elaborate system for trialing new drugs could break down if an unexpected court decision is upheld. In May the US Court of Appeals for the DC Circuit ruled that patients with life-threatening diseases have a constitutional right to drugs whose efficacy is still in doubt.

"It's a huge, huge, devastating decision," William Schultz, a former deputy commissioner for policy at the US Food and Drug Administration told the New England Journal of Medicine. "It would be very hard to figure out which drugs work," says Schultz; the incentive for conducting clinical trials "would seriously diminish"; and permitting companies to market drugs without evidence of efficacy would create "massive opportunity for fraud, involving people who are very sick and very desperate."

The other side of the question is the right of patients who may die anyway to grasp at the straw of extending their lives. "Dying people ought to have special latitude to work with the growing edge of science," says Dale O'Brien, the medical director of the patient advocacy group Lorenzen Cancer Foundation. The author of the controversial decision, Judge Judith Rogers, opined that "The prerogative asserted by the FDA -- to prevent a terminally ill patient from using potentially life-saving medication to which those in Phase II clinical trials have access... impinges upon an individual liberty deeply rooted in our nation's history and tradition of self-preservation."

The movement for access before approval is gathering strength. Kansas Senator Sam Brownback introduced a bill last November which would allow patients who have exhausted all other treatment option to receive experimental drugs, provided that they waive the right to sue the manufacturer and allow collection of their clinical data. The Society for Clinical Trials opposes the bill. Although it purports to cover only the dying, warns Colin Begg, a biostatistician at Memorial Sloan-Kettering Cancer Center, and a member of the Society's board, "it's not at all clear that things would stop there". ~ NEJM, Aug 3   

EXPLOITATION IN PAKISTAN

Pakistani child at work When they pick up a pair of surgical scissors, doctors may be supporting child labour in Pakistan, a British doctors claims in the British Medical Journal. London-based surgeon Mahmood Bhutta says that Pakistan produces about 20% of the world's surgical instruments, mostly in the city of Sialkot. About 50,000 people work there producing stainless steel instruments, of whom about 7,700 are children. A pair of scissors may cost about US$80, but the German companies which market them pay the manufacturer only about $1.25. Dr Bhutta proposes that adult employees receive a fair wage so that their children will not have to work. He opposes a boycott because this could send workers deeper into poverty. ~ news@nature.com, July 28   

IN BRIEF: Thailand; drug trial

THAILAND: Fertility tourism is booming in Thailand, with the cost of IVF a mere one-third of rates in Europe or the US. The largest clinic, the Jetanin Institute for Assisted Reproduction, has started offering sex selection, as well as pre-implantation genetic diagnosis. Six weeks ago, the Ramkhamhaeng hospital group also began offering a range of reproductive services aimed at foreigners from countries where such practices are banned. ~ Taipei Times, Aug 7

TGN-1412: The man who was most severely affected by a severe reaction to a monoclonal antibody in a London drug trial in March has now been told that he is showing early signs of cancer. His doctors have also told him that he risks developing multiple sclerosis, arthritis and chronic fatigue. David Oakley, 35, told the Mail on Sunday that he participated in the trial to raise £2,000 for his wedding. ~ Guardian, Aug 6   

 

  

How to support BioEdge
BioEdge and ABI's other services rely completely upon the generosity of private benefactors and volunteer workers. ABI has no institutional backing. If you would like to support the best bioethics news service on the Web, you can do it painlessly through Paymate, a thoroughly reliable payment service which is affiliated with the internet auction site eBay.

Just access the Paymate website and follow the instructions. You will need to fill in our email address, which is bioedge@australasianbioethics.org. You will also have to give your credit card details and an amount in Australian or US dollars. Thanks!

  

 

To subscribe to our weekly email newsletter,
click here for the HTML version.
click here for the text version.
To cancel your newsletter subscription, click here.

Australasian Bioethics Information
ISSN 1446-2117
Website:www.australasianbioethics.org
BioEdge editor: Michael Cook
New Zealand Contributing Editor: Carolyn Moynihan


The BioEdge privacy policy
Your subscription information will be kept private and is not publicly accessible.
Your email address and other information will never be sold to a third party or given out
without your consent. You may cancel your subscription at any time.